Cargando…
siRNA for Influenza Therapy
Influenza virus is one of the most prevalent and ancient infections in humans. About a fifth of world’s population is infected by influenza virus annually, leading to high morbidity and mortality, particularly in infants, the elderly and the immunocompromised. In the US alone, influenza outbreaks le...
Autor principal: | Barik, Sailen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185718/ https://www.ncbi.nlm.nih.gov/pubmed/21994689 http://dx.doi.org/10.3390/v2071448 |
Ejemplares similares
-
Intranasal Delivery of Antiviral siRNA
por: Barik, Sailen
Publicado: (2010) -
Therapy of Respiratory Viral Infections with Intranasal siRNAs
por: Barik, Sailen, et al.
Publicado: (2014) -
Treating Respiratory Viral Diseases with Chemically Modified, Second Generation Intranasal siRNAs
por: Barik, Sailen
Publicado: (2008) -
New treatments for influenza
por: Barik, Sailen
Publicado: (2012) -
Inhibition of Viral RNA-Dependent RNA Polymerases by Nucleoside Inhibitors: An Illustration of the Unity and Diversity of Mechanisms
por: Barik, Sailen
Publicado: (2022)